Genocea Biosciences Inc Sustainability Reports
Genocea Biosciences Inc. was a biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The company's platform was designed to profile a patient's T cell responses to identify specific antigens for vaccine development.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300BRZWG25RBYA369
FIGI: BBG001V0GNQ6
4 reports from 2016 to 2019
